RSS

Nick Sutcliffe

Recently, there has been a shift within the pharmaceutical industry veering its R&D away from the traditional corporate campuses and moving them to new collaborative biotech clusters. Nick Sutcliffe, discusses the risks and opportunities of the trend Read more

Opinion